Inhaled glucocorticoids and COPD exacerbations.

Inhaled glucocorticoids and COPD exacerbations.

Библиографические подробности
Главные авторы:	Brightling, C, Pavord, I, Bafadhel, M
Формат:	Journal article
Язык:	English
Опубликовано:	2015

Схожие документы

Inhaled corticosteroids in COPD.
по: Brightling, C, и др.
Опубликовано: (1999)

Quadrupling inhaled glucocorticoid dose to abort asthma exacerbations
по: McKeever, T, и др.
Опубликовано: (2018)

Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.
по: Bafadhel, M, и др.
Опубликовано: (2014)

COPD: an inhaled corticosteroid-resistant, oral corticosteroid-responsive condition.
по: Saha, S, и др.
Опубликовано: (2006)

Inhaled corticosteroids in COPD (multiple letters) [1]
по: Hart, S, и др.
Опубликовано: (1999)

Aspergillus fumigatus during stable state and exacerbations of COPD.
по: Bafadhel, M, и др.
Опубликовано: (2014)

The Use of Inhaled Corticosteroids to Prevent Acute Exacerbations of COPD: A Pro/Con Debate
по: Russell, R, и др.
Опубликовано: (2019)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
по: Siddiqui, S, и др.
Опубликовано: (2018)

Association Between Pathogens Detected Using Quantitative Polymerase Chain Reaction With Airway Inflammation in COPD at Stable State and Exacerbations.
по: Barker, B, и др.
Опубликовано: (2015)

Blood Eosinophils and outcomes in severe hospitalized exacerbations of COPD
по: Bafadhel, M, и др.
Опубликовано: (2016)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
по: Siddiqui SH, и др.
Опубликовано: (2018-11-01)

COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils
по: Eltboli, O, и др.
Опубликовано: (2014)

The Importance of Inhaler Adherence to Prevent COPD Exacerbations
по: Jose R. Jardim, и др.
Опубликовано: (2019-04-01)

Exacerbations of COPD
по: Pavord ID, и др.
Опубликовано: (2016-02-01)

Lung microbiome dynamics in COPD exacerbations
по: Wang, Z, и др.
Опубликовано: (2016)

The acute wheezy adult with airways disease in the emergency department: a retrospective case-note review of exacerbations of COPD
по: Russell, R, и др.
Опубликовано: (2019)

Is it time to give up on "self-management" of COPD exacerbations?
по: Ramakrishnan, S, и др.
Опубликовано: (2020)

Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial.
по: Siva, R, и др.
Опубликовано: (2014)

COPD exacerbation phenotypes: The next frontier
по: Moran, A, и др.
Опубликовано: (2019)

Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function
по: Bafadhel M, и др.
Опубликовано: (2015-06-01)

Biological exacerbation clusters demonstrate asthma and COPD overlap with distinct mediator and microbiome profiles
по: Ghebre, M, и др.
Опубликовано: (2018)

Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD.
по: Bafadhel, M, и др.
Опубликовано: (2011)

The acute wheezy adult with airways disease in the emergency department: a retrospective case-note review of exacerbations of COPD
по: Russell REK, и др.
Опубликовано: (2019-05-01)

Benralizumab for the prevention of COPD exacerbations
по: Criner, G, и др.
Опубликовано: (2019)

The role of CT scanning in multidimensional phenotyping of COPD.
по: Bafadhel, M, и др.
Опубликовано: (2011)

Blood eosinophils to guide inhaled maintenance therapy in a primary care COPD population
по: Helen F. Ashdown, и др.
Опубликовано: (2021-02-01)

Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial
по: Siva R, и др.
Опубликовано: (2014-02-01)

Use of dry powder inhalers in acute exacerbations of asthma and COPD
по: Olof Selroos, и др.
Опубликовано: (2009-04-01)

Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.
по: Siva, R, и др.
Опубликовано: (2007)

Prednisolone response in patients with COPD.
по: Pavord, I, и др.
Опубликовано: (2004)

Eosinophils in COPD: just another biomarker?
по: Bafadhel, M, и др.
Опубликовано: (2017)

Characterising non-eosinophilic COPD
по: Hambleton, K, и др.
Опубликовано: (2015)

Cognitive function and inhaler technique following recovery from exacerbations of COPD
по: Benjamin E. Henkle, и др.
Опубликовано: (2023-05-01)

COPD exacerbations: transforming outcomes through research
по: Hurst, JR, и др.
Опубликовано: (2018)

Temporarily quadrupling the dose of inhaled steroid to prevent asthma exacerbations: FAST
по: McKeever, T, и др.
Опубликовано: (2018)

Use of glucocorticoids in patients with COPD exacerbations in China: a retrospective observational study
по: Jing Zhang, и др.
Опубликовано: (2018-04-01)

Blood eosinophil count and exacerbation risk in patients with COPD.
по: Kerkhof, M, и др.
Опубликовано: (2017)

Blood eosinophil count and GOLD stage predict response to maintenance azithromycin treatment in COPD patients with frequent exacerbations
по: Djamin, R, и др.
Опубликовано: (2019)

Renaming COPD exacerbations: the UK respiratory nursing perspective
по: Christine Mwasuku, и др.
Опубликовано: (2021-09-01)

Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
по: Vestbo J, и др.
Опубликовано: (2019-04-01)